ABCAP:AQUISEUABC arbitrage SA Analysis
Data as of 2026-03-16 - not real-time
₹310.45
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock is currently trading below its 20‑day and 50‑day moving averages, indicating a short‑term weakness. However, the 200‑day average remains beneath the price, suggesting a longer‑term baseline still supports the level. The RSI has slipped into the low‑30s, a classic oversold signal that could foreshadow a bounce. The MACD histogram is negative and the line sits beneath its signal, reinforcing bearish momentum on the chart. Volume has been rising, providing the recent price action with decent liquidity. Volatility is elevated, reflecting sizable price swings over the past month.
On the fundamentals side, revenue is expanding at a pace well above thirty percent year‑over‑year, while margins are comfortably in double‑digits. The trailing PE sits noticeably higher than the industry average, flagging an overvalued snapshot, but the forward PE contracts to a more reasonable level. The balance sheet is heavily levered, with debt far outweighing cash, which raises financial risk. The company does not pay a dividend, making income‑focused investors uneasy. Analyst consensus is strongly positive, with a “strong‑buy” rating and target prices implying roughly thirty percent upside. Combined with a market sentiment leaning toward greed, the stock presents a mixed picture of upside potential tempered by valuation and leverage concerns.
On the fundamentals side, revenue is expanding at a pace well above thirty percent year‑over‑year, while margins are comfortably in double‑digits. The trailing PE sits noticeably higher than the industry average, flagging an overvalued snapshot, but the forward PE contracts to a more reasonable level. The balance sheet is heavily levered, with debt far outweighing cash, which raises financial risk. The company does not pay a dividend, making income‑focused investors uneasy. Analyst consensus is strongly positive, with a “strong‑buy” rating and target prices implying roughly thirty percent upside. Combined with a market sentiment leaning toward greed, the stock presents a mixed picture of upside potential tempered by valuation and leverage concerns.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price testing support level
- bearish MACD divergence
- oversold RSI indicating potential rebound
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- strong revenue growth momentum
- forward PE suggests valuation compression
- analyst consensus and upside target
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- expanding financial services footprint
- large addressable market in India
- long‑term earnings growth potential despite high leverage
Key Metrics & Analysis
Financial Health
Revenue Growth31.40%
Profit Margin11.07%
P/E Ratio23.4
Debt/Equity459.78
P/B Ratio2.5
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI32.2
Support₹309.30
Resistance₹359.90
MA 20₹337.11
MA 50₹346.09
MA 200₹306.76
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Target Price₹407.08
Upside/Downside31.13%
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.21
Volatility31.49%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.